Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|November 15, 2008
What is triple-negative breast cancer?William J Irvin, Lisa A Carey
The Oncologist|April 26, 2012
Tamoxifen and CYP2D6: a contradiction of dataDaniel L Hertz, Howard L McLeod, William J Irvin
Clinical Breast Cancer|December 15, 2010
Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancerWilliam J Irvin, Robert Z Orlowski, Wing-Keung Chiu, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients with CancerDeloris Veney, Lai Wei, Amanda E Toland, et al.
Pharmacogenetics and Genomics|September 7, 2017
Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatmentLauren A Marcath, Allison M Deal, Emily Van Wieren, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2023
Oncologists' responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional studyTeresa M Salgado, Rotana M Radwan, Erin Hickey Zacholski, et al.
Cancer Medicine|September 11, 2024
A video intervention to improve patient understanding of tumor genomic testing in patients with cancerDeloris J Veney, Lai Y Wei, Amanda E Toland, et al.
JAMA|April 29, 2024
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized TrialWendy Y Chen, Karla V Ballman, Ann H Partridge, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 1, 2024
Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists' practicesTeresa M Salgado, Poorva B Birari, Mona Alshahawey, et al.
JNCI Cancer Spectrum|April 2, 2025
Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trialHanna Bandos, Sungjin Kim, N Lynn Henry, et al.
Pageof 3